Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (89046)	4/12/2012 3:12:09 PM
From: Lazarus	Respond to of 217781

ya think? click each one to read more............ WASHINGTON — Federal health officials and prosecutors, frustrated that they have been unable to stop illegal kickbacks to doctors from drug and device companies, are investigating doctors who take money for using these products. in general, oncologists make money by providing chemotherapy, even when it has little chance of success. Oncologists naturally dislike telling cancer patients that they have exhausted all available treatments. Ending chemotherapy, after all, means acknowledging that a patient’s disease has become terminal. unlike other doctors, medical oncologists (doctors who prescribechemotherapy) can profit directly from prescribing certain drugs whenthey administer them in their offices. Oncologists can purchase chemotherapyat lower prices than the amounts that Medicare and other privateinsurance companies pays them. Then they pocket the difference. Thismark-up, which historically can be as high as 86%, is called thechemotherapy concession.